Literature DB >> 25404301

Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent.

Twana Alkasalias1, Emilie Flaberg2, Vladimir Kashuba3, Andrey Alexeyenko4, Tatiana Pavlova2, Andrii Savchenko2, Laszlo Szekely2, George Klein5, Hayrettin Guven2.   

Abstract

Normal human and murine fibroblasts can inhibit proliferation of tumor cells when cocultured in vitro. The inhibitory capacity varies depending on the donor and the site of origin of the fibroblast. We showed previously that effective inhibition requires formation of a morphologically intact fibroblast monolayer before seeding of the tumor cells. Here we show that inhibition is extended to motility of tumor cells and we dissect the factors responsible for these inhibitory functions. We find that inhibition is due to two different sets of molecules: (i) the extracellular matrix (ECM) and other surface proteins of the fibroblasts, which are responsible for contact-dependent inhibition of tumor cell proliferation; and (ii) soluble factors secreted by fibroblasts when confronted with tumor cells (confronted conditioned media, CCM) contribute to inhibition of tumor cell proliferation and motility. However, conditioned media (CM) obtained from fibroblasts alone (nonconfronted conditioned media, NCM) did not inhibit tumor cell proliferation and motility. In addition, quantitative PCR (Q-PCR) data show up-regulation of proinflammatory genes. Moreover, comparison of CCM and NCM with an antibody array for 507 different soluble human proteins revealed differential expression of growth differentiation factor 15, dickkopf-related protein 1, endothelial-monocyte-activating polypeptide II, ectodysplasin A2, Galectin-3, chemokine (C-X-C motif) ligand 2, Nidogen1, urokinase, and matrix metalloproteinase 3.

Entities:  

Keywords:  cancer-associated fibroblast; extracellular matrix; motility; soluble factors; tumor microenvironment

Mesh:

Substances:

Year:  2014        PMID: 25404301      PMCID: PMC4260581          DOI: 10.1073/pnas.1419554111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Nectins and nectin-like molecules: roles in contact inhibition of cell movement and proliferation.

Authors:  Yoshimi Takai; Jun Miyoshi; Wataru Ikeda; Hisakazu Ogita
Journal:  Nat Rev Mol Cell Biol       Date:  2008-08       Impact factor: 94.444

2.  Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system.

Authors:  Fortunata Iacopino; Cristiana Angelucci; Gigliola Sica
Journal:  Anticancer Res       Date:  2012-05       Impact factor: 2.480

3.  Extension of life-span by introduction of telomerase into normal human cells.

Authors:  A G Bodnar; M Ouellette; M Frolkis; S E Holt; C P Chiu; G B Morin; C B Harley; J W Shay; S Lichtsteiner; W E Wright
Journal:  Science       Date:  1998-01-16       Impact factor: 47.728

Review 4.  Why do we not all die of cancer at an early age?

Authors:  George Klein; Stefan Imreh; Eugene R Zabarovsky
Journal:  Adv Cancer Res       Date:  2007       Impact factor: 6.242

5.  CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth.

Authors:  Martin Augsten; Christina Hägglöf; Eleonor Olsson; Claudia Stolz; Panagiotis Tsagozis; Tetyana Levchenko; Mitchell J Frederick; Ake Borg; Patrick Micke; Lars Egevad; Arne Ostman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-13       Impact factor: 11.205

6.  A G2/M cell cycle block in transformed cells by contact with normal neighbors.

Authors:  David Allard; Michael Stoker; Ermanno Gherardi
Journal:  Cell Cycle       Date:  2003 Sep-Oct       Impact factor: 4.534

7.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.

Authors:  Cedric Gaggioli; Steven Hooper; Cristina Hidalgo-Carcedo; Robert Grosse; John F Marshall; Kevin Harrington; Erik Sahai
Journal:  Nat Cell Biol       Date:  2007-11-25       Impact factor: 28.824

8.  Toward a genetics of cancer resistance.

Authors:  George Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

9.  Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner.

Authors:  Adam W Studebaker; Gianluca Storci; Jillian L Werbeck; Pasquale Sansone; A Kate Sasser; Simona Tavolari; Tim Huang; Michael W Y Chan; Frank C Marini; Thomas J Rosol; Massimiliano Bonafé; Brett M Hall
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

10.  Growth inhibition of polyoma-transformed cells by contact with static normal fibroblasts.

Authors:  M G Stoker; M Shearer; C O'Neill
Journal:  J Cell Sci       Date:  1966-09       Impact factor: 5.285

View more
  36 in total

1.  Aging-related tumor associated fibroblasts changes could worsen the prognosis of GBM patients.

Authors:  Hongwang Song; Xiaojun Fu; Chenxing Wu; Shouwei Li
Journal:  Cancer Cell Int       Date:  2020-10-08       Impact factor: 5.722

2.  Contribution of fibroblasts to tunnel formation and inflammation in hidradenitis suppurativa/ acne inversa.

Authors:  John W Frew; Kristina Navrazhina; Meaghan Marohn; Pei-Ju C Lu; James G Krueger
Journal:  Exp Dermatol       Date:  2019-07-03       Impact factor: 3.960

Review 3.  The double edge sword of fibrosis in cancer.

Authors:  Chelsea Chandler; Tianshi Liu; Ronald Buckanovich; Lan G Coffman
Journal:  Transl Res       Date:  2019-02-21       Impact factor: 7.012

4.  RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo.

Authors:  Twana Alkasalias; Andrey Alexeyenko; Katharina Hennig; Frida Danielsson; Robert Jan Lebbink; Matthew Fielden; S Pauliina Turunen; Kaisa Lehti; Vladimir Kashuba; Harsha S Madapura; Benedek Bozoky; Emma Lundberg; Martial Balland; Hayrettin Guvén; George Klein; Annica K B Gad; Tatiana Pavlova
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

Review 5.  Engineering Multidimensional Evolutionary Forces to Combat Cancer.

Authors:  Caroline E McCoach; Trever G Bivona
Journal:  Cancer Discov       Date:  2019-04-16       Impact factor: 39.397

6.  Cooperativity between stromal cytokines drives the invasive migration of human breast cancer cells.

Authors:  Yair Elisha; Yael Sagi; Georg Klein; Ravid Straussman; Benjamin Geiger
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

7.  Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression.

Authors:  Adrián Blanco-Gómez; Lourdes Hontecillas-Prieto; Roberto Corchado-Cobos; Natalia García-Sancha; Jesús Pérez-Losada; Sonia Castillo-Lluva; Nélida Salvador; Andrés Castellanos-Martín; María Del Mar Sáez-Freire; Marina Mendiburu-Eliçabe; Diego Alonso-López; Javier De Las Rivas; Mar Lorente; Ana García-Casas; Sofía Del Carmen; María Del Mar Abad-Hernández; Juan Jesús Cruz-Hernández; César Augusto Rodríguez-Sánchez; Juncal Claros-Ampuero; Begoña García-Cenador; Javier García-Criado; Akira Orimo; Thomas Gridley
Journal:  Cancer Res       Date:  2020-10-06       Impact factor: 12.701

8.  Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer.

Authors:  Takeshi Sasaki; Kenichiro Ishii; Yoichi Iwamoto; Manabu Kato; Manabu Miki; Hideki Kanda; Kiminobu Arima; Taizo Shiraishi; Yoshiki Sugimura
Journal:  Lab Invest       Date:  2015-12-07       Impact factor: 5.662

9.  Dynamic culture improves cell reprogramming efficiency.

Authors:  Junren Sia; Raymond Sun; Julia Chu; Song Li
Journal:  Biomaterials       Date:  2016-03-22       Impact factor: 12.479

10.  Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways.

Authors:  Anastasia V Suhovskih; Vladimir I Kashuba; George Klein; Elvira V Grigorieva
Journal:  Cell Adh Migr       Date:  2016-04-25       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.